Today: 21 May 2026
Browse Category

TSX:BN 30 November 2025 - 3 December 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation closed at US$46.46 on the NYSE and C$65.01 on the TSX on December 2, 2025, valuing the company at over US$100 billion. HSBC Holdings increased its stake by 3.7% in Q2, while institutional ownership in Brookfield now exceeds 60%. The board declared a US$0.06 quarterly dividend, payable December 31. BN shares are up about 16% over the past year.
3 December 2025
···
Brookfield Corporation (BN) Stock: Institutional Buying, AI Infrastructure Push and Preferred Share Deal – Update for November 29, 2025

Brookfield Corporation (BN) Stock: Institutional Buying, AI Infrastructure Push and Preferred Share Deal – Update for November 29, 2025

Regulatory filings on November 29, 2025, showed Korea Investment CORP and Scotia Capital Inc. increased their stakes in Brookfield Corporation after the company’s C$250 million preferred share offering and new AI infrastructure plans. Brookfield stock closed at $47.00 on the NYSE and C$65.98 on the TSX on November 28, with a market cap near $117 billion and a P/E ratio around 165x trailing earnings.
30 November 2025
··

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop